ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 43

Deaths Associated with Ankylosing Spondylitis in France from 1969 to 2009

Clement Prati1, Daniel Wendling2 and Xavier Guillot3, 1Rhumatologie, Hopital Jean Minjoz, Besancon, France, 2Service de Rhumatologie, CHU J Minjoz, Besancon, France, 3rheumatology, Besançon, France

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: ankylosing spondylitis (AS) and death, Co-morbidities

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Epidemiology and Public Health: Osteoporosis, Non-Inflammatory Arthritis and More

Session Type: Abstract Submissions (ACR)

Background/Purpose

Ankylosing spondylitis (AS) is a chronic inflammatory joint disease that can lead to chronic pain in the axial and peripheral joints and to functional impairments. AS is a systemic disease that can cause extraarticular manifestations which could participate to excess mortality. The aim of the study is to describe characteristics of deaths for which AS was mentioned on the death certificate as either the underlying cause or anywhere on the death certificate and to analyze trends in AS related mortality from 1969 to 2009 in France.

Methods

Data were obtained from the Centre of Epidemiology on the Medical Causes of Death (CépiDc) for individuals aged 18 years and over died in France. Owing to implementation of International Classification of Diseases (ICD) 8, ICD-9 and ICD-10 for recording causes of deaths, three separate periods were analyzed (1969-78 ; 1979–99 and 2000–09). Initial, terminal and associated causes of deaths were analyzed. Initial Causes of deaths were compared with deaths of French general population in the same periods (CIM9 and 10).

Results

In the global period (1969-2009), AS appeared in 2942 deaths certificates, 2292 men (mean age of death 68,7 years) and 650 women (mean age of  75,8), 601 between 1969-78 (ICD8), 1471 between 1979-1999 (ICD9) and 867 between 2000 and 2009 (ICD10). There is a trend that AS decreases life expectancy in men compared with general population. The number of deaths with AS on the death certificates is increasing due to change of ICD and increase of diagnosis. AS is mentioned as initial cause in 38% in 1969-1978, 33% in 1979-1999 and 5% in 2000-2009. Apart from AS, most frequent initial causes are diseases of the circulatory system (28,5 % in ICD8,  23,1% in ICD9 and 26,5% in ICD10 ; neoplasms (7,8%, 10,2% and 16,3%) ; diseases of the respiratory system  (7,5%, 11,1% and 9,4%) and external causes of mortality (3,5%, 7,8% and 13,1%). Compared to general population there is less deaths caused by neoplasm, but more caused by infectious, genitourinary diseases and external causes of mortality. Most frequent associated causes are diseases of the circulatory system (22,2%, 34,4% and 23,7%).

Conclusion

The manner of death coding varies according to ICD. Our study is the first to analyze data from deaths certificate. Diseases of the circulatory system are the most frequent initial and associated causes of death. But compared to general population, infectious, genitourinary diseases and external causes of mortality are more frequent in AS.


Disclosure:

C. Prati,
None;

D. Wendling,
None;

X. Guillot,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/deaths-associated-with-ankylosing-spondylitis-in-france-from-1969-to-2009/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology